Further, the phosphorylation of ERK and AKT in COMP-treated hepatocellular carcinoma cells resulted in the activation of MEK/ERK and PI3K/AKT pathways and eventually induced the migration ability of cells [15]. Here, MAP2K7 is linked to hepatocellular carcinoma.